Mechanical pressure is the engine that drives most diabetic foot ulcers. When peripheral neuropathy removes the protective sensation of pain, repetitive load on a small area of the sole goes unnoticed, tissue breaks down, and a wound forms. Crucially, that same unrelieved pressure also prevents the wound from closing. For this reason, the International Working Group on the Diabetic Foot (IWGDF) describes the redistribution of mechanical stress — offloading — as arguably the single most important intervention for healing a plantar diabetic foot ulcer.
Why Offloading Determines Healing
A neuropathic plantar ulcer sits beneath a foot that continues to bear the full force of walking. Each step concentrates pressure on the wound bed, disrupting the fragile new tissue that healing requires. No dressing, topical agent, or antibiotic can overcome the repetitive trauma of an unprotected step. The 2023 IWGDF offloading guideline, developed through systematic review and meta-analysis using the GRADE framework, makes the priority explicit: relieving pressure is the foundation on which every other element of wound care is built (Bus et al., 2023).
The practical consequence is a treatment hierarchy. Devices that the patient cannot take off outperform those that can, because adherence — not the device material itself — is the deciding variable in real-world healing.
The Evidence for Non-Removable Knee-High Devices
The IWGDF names a non-removable, knee-high offloading device as the first-choice treatment for a neuropathic plantar forefoot or midfoot ulcer (Bus et al., 2023). The total contact cast (TCC) is the archetype: a closely molded cast that distributes load across the entire lower leg and foot while immobilizing the wound.
A secondary analysis of step activity illustrates why irremovability matters. Among patients with neuropathic plantar ulcers, 93% of those treated with a total contact cast healed, compared with 65% of those using a removable cast walker, with mean healing times of roughly 77 versus 138 days. Patients in removable devices simply took more steps, exposing the wound to more cumulative pressure (Wendland et al., 2023). When a device can be removed, it frequently is — often for understandable reasons of comfort, bathing, or sleep — and each unprotected step delays closure.
When the First Choice Is Not Possible
Non-removable casts are not appropriate for every patient. Active infection, significant ischemia, or the need for frequent wound inspection can make a sealed cast unsafe. The IWGDF therefore offers a stepped pathway: where non-removable devices are contraindicated or not tolerated, a removable knee-high or ankle-high device is the second choice, and appropriately fitting footwear combined with felted foam is the third (Bus et al., 2023).
Clinicians have also adapted the cast itself to widen its use. A total contact softcast — a non-removable but more flexible alternative — produced healing rates comparable to a conventional rigid cast in a retrospective series, with a mean healing time of 5.5 versus 8.4 weeks, suggesting the principle of irremovability can be preserved while easing some of the burden on daily life (Vierhout et al., 2022). Windowed cast designs that allow the wound to be viewed without removing the device have been described for patients who need both immobilization and regular inspection.
Offloading Beyond the Ulcer: Charcot Neuroarthropathy
Offloading is also central to managing active Charcot neuroarthropathy, where inflammation in the neuropathic foot can progress to fracture and collapse. Timing appears to matter. In a cohort of 198 Charcot events, casting begun at the earliest inflammatory phase (stage 0, before established fracture or deformity) was associated with shorter total casting duration (median 75 versus 111 days), a lower rate of recurrent Charcot events, and no need for reconstructive surgery in that group, compared with nearly 9% among those offloaded later (Schoug et al., 2024). Early recognition and prompt immobilization can change the trajectory of the disease.
Key Takeaways
Offloading is not an adjunct to diabetic foot ulcer care — it is the core of it. Current evidence and the 2023 IWGDF guideline converge on a clear order of preference: a non-removable knee-high device first, a removable device second, and protective footwear with felted foam third. The recurring theme across studies is adherence; devices that stay on the foot heal wounds faster because they remove the pressure consistently rather than intermittently. In Charcot neuroarthropathy, the same principle applies, with the added lesson that earlier offloading yields better structural outcomes. For anyone living with neuropathy and a foot wound, understanding why pressure relief is non-negotiable is the first step toward healing and toward preventing the infections and amputations that unhealed ulcers can cause.
References
Bus SA, Armstrong DG, Crews RT, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2023;40(3):e3647.
Wendland DM, Kline PW, Bohnert KL, Biven TM, Sinacore DR. Offloading of Diabetic Neuropathic Plantar Ulcers: Secondary Analysis of Step Activity and Ulcer Healing. Advances in Skin & Wound Care. 2023;36(4):194–200.
Vierhout BP, Visser R, Hutting KH, El Moumni M, van Baal JG, de Vries JPM. Comparing a non-removable total contact cast with a non-removable softcast in diabetic foot ulcers. Diabetes Research and Clinical Practice. 2022;191:110036.
Schoug J, Katzman P, Fagher K, Löndahl M. Charcot Foot Offloading in Stage 0 Is Associated With Shorter Total Contact Cast Treatment and Lower Risk of Recurrence and Reconstructive Surgery: A Pilot Study. Diabetes Care. 2024;47(2):252–258.
Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes/Metabolism Research and Reviews. 2020;36(Suppl 1):e3266.
Comments
